The targeting of NAD + biosynthetic pathways with the inhibitors of nicotinamide phosphoribosyltransferase (NAMPT) or nicotinate phosphoribosyltransferase (NAPRT) showed anti-tumor effects and exerted sensitization to docetaxel in xenograft mice. This evidence concerns the gene NAPRT and neoplasm.